Where the microbiome actually fits into digestion
Digestion is mostly your own biology. Your stomach and small intestine, using human enzymes and bile, break down and absorb the great majority of the starch, protein and fat in a meal. That work is finished before your gut microbiome has any significant role in it.
What your enzymes cannot break down keeps travelling. Dietary fibre, resistant starch and certain other carbohydrates pass through the small intestine largely intact and arrive in the large intestine, where the dense microbial community lives [1][2]. This is the point at which the microbiome enters the story — not as a partner in digesting your dinner, but as an ecosystem that lives on the part of your dinner you could not digest.
That distinction matters for reading any microbiome result. A stool test is not a measurement of how well you digest food. It is a description of the community that specialises in what escaped digestion.
- Host process
- Microbial process
- Not directly measured
- Sequencing-observable
-
1 Host process
Food intake
A meal enters the digestive tract as a mixture of digestible and non-digestible components.
-
2 Host process
Host digestion — stomach and small intestine
Human enzymes break down most starch, protein and fat. This is your own biology, not your microbiome.
-
3 Host process
Absorption of host-digestible nutrients
Sugars, amino acids and fatty acids are absorbed across the small-intestinal wall.
-
4 Host process
Resistant substrates reach the colon
Dietary fibre, resistant starch and other carbohydrates human enzymes cannot break down continue into the large intestine.
-
5 Microbial process
Microbial fermentation
Colonic bacteria break down those substrates. Different organisms specialise, and the products of one become the substrate of another.
-
6 Not directly measured
Microbial metabolites and ecological interactions
Fermentation yields short-chain fatty acids and gases, alongside transformations of compounds such as bile acids.
-
7 Not directly measured
Host–microbial interface
Metabolites are absorbed or used locally; transit, stool form and the gut environment shape, and are shaped by, the community.
-
8 Sequencing-observable
Stool sample → sequencing
A stool sample captures microbial material largely from the distal gut. Sequencing describes which organisms are present and in what proportions.
The pathway from a meal to a microbial community, and the point at which a stool sample enters it. Only the final step is what sequencing actually observes.
What reaches the colon
The clearest physiological evidence for this hand-off is chemical. In a landmark human study measuring the contents of the whole gut, total short-chain fatty acid concentration was low in the terminal ileum — the end of the small intestine — at 13 ± 6 mmol/kg, and roughly ten times higher immediately downstream in the caecum, at 131 ± 9 mmol/kg [6]. Fermentation begins in earnest where the colon begins.
The composition of the community changes just as sharply. The small intestine hosts a distinct microbial population, adapted to rapidly taking up and converting simple carbohydrates, and it fluctuates over time [5]. It is not a smaller version of the colon.
How much material makes this journey depends on what you eat, and the physical properties of different fibres — solubility, viscosity, fermentability — vary enormously with their origin and processing, which is why different fibres behave so differently in the gut [2]. Not every fermentable substrate qualifies as a prebiotic, incidentally: the consensus definition requires that a health benefit actually be documented, a bar set deliberately to constrain how the term is used in research and in product marketing [3].
How microbes break down fibre and resistant carbohydrates
Fermentation in the colon is anaerobic. Without oxygen, bacteria extract energy from carbohydrate by breaking it into smaller organic acids and gases, and those products accumulate. Acetate, propionate and butyrate are the acids that dominate [10].
No single organism does the whole job. Some bacteria specialise in the first, hardest step — cleaving complex polysaccharides into smaller fragments. Others cannot degrade the original fibre at all and instead live on the products of the first group.
Cross-feeding: a chain, not a single step
This hand-off is called cross-feeding, and it is one of the best-characterised mechanisms in gut microbiology. In defined laboratory co-cultures, butyrate-producing bacteria that cannot break down inulin-type fructans themselves nonetheless produced butyrate when grown alongside a Lactobacillus supplying lactate and simple sugars and a Bifidobacterium supplying acetate [12]. Related experiments show hydrogen and formate being passed between species to enable butyrate formation [13].
Lactate is a useful illustration. Many gut microbes produce it, yet it usually does not build up in a healthy colon, because a relatively small number of lactate-consuming organisms convert it onward into propionate, butyrate or acetate [10]. An ecosystem's stability often rests on these quiet conversions rather than on the abundance of any one organism.
Short-chain fatty acids: what they are and where they go
Short-chain fatty acids are the main products of colonic fermentation. Acetate is the most abundant, with propionate and butyrate present in smaller amounts, and the proportions vary along the length of the colon and between people [6].
They are not simply waste. Short-chain fatty acids act as energy substrates, activate specific cell-surface receptors and influence gene expression through histone deacetylase inhibition — which is why they are studied so intensively across so many areas of physiology [7]. They also acidify the colon: luminal pH rises from 5.6 ± 0.2 in the caecum to 6.6 ± 0.1 in the descending colon, inversely tracking short-chain fatty acid concentration [6].
Where each one ends up differs, and this is the part most often misread.
Acetate
Acetate is the most abundant and the most systemically available. In a stable-isotope study in twelve healthy adults, 36% of colonic acetate reached the systemic circulation. Around a quarter of it — 24% — was converted by the microbiota into butyrate rather than being absorbed as acetate [8].
Propionate
Propionate is largely taken up by the liver. Only about 9% reached the systemic circulation in the same study, and roughly 6% of colonic propionate was incorporated into glucose [8].
Butyrate
Butyrate barely leaves the gut at all. Just 2% of colonic butyrate reached the systemic circulation, because it is the preferred energy source of the cells lining the colon and is consumed locally [1][8].
This is also why sequencing and metabolite measurement answer different questions. Sequencing describes who is present and what genes they carry; it does not measure how much of any metabolite was made.
Gas, and why volume is not the whole story
Fermentation produces gas as well as acids — carbon dioxide, hydrogen and methane among them, with the mixture shaped strongly by what you have eaten [14]. Substrate matters measurably: in a randomised crossover trial, breath hydrogen and methane rose more after wheat than after rice in the same individuals, alongside higher bloating scores [16].
But the relationship between gas and discomfort is not the straightforward one most people assume. In a controlled study, people who complained of flatulence evacuated essentially the same volume of gas after a standard meal as healthy controls — 262 ± 22 mL versus 265 ± 25 mL — while reporting roughly fourteen times the discomfort [15]. On a deliberately gas-producing diet, both groups again produced similar volumes. Patients did pass gas about three times as often across the day; the authors concluded that they tolerate intestinal gas poorly — a difference in tolerance more than in the volume produced per meal. Consistent with that, a randomised placebo-controlled crossover trial of an enzyme intended to reduce gas production found it no better than placebo for symptoms, breath hydrogen or breath methane [17].
Bile acids: chemistry your bacteria perform
Bile acids are made by your liver from cholesterol and released to help you absorb fat. Gut bacteria then chemically modify them — removing the amino acid conjugate through bile salt hydrolase activity, and converting primary bile acids into secondary bile acids through 7α-dehydroxylation [18]. The circulating bile acid pool is therefore a joint product of human and microbial biochemistry.
This chemistry is well established. What it means for any individual is less settled: the literature describing links between secondary bile acids and gastrointestinal conditions is largely associative, and much of the detailed mechanistic work has been done in gnotobiotic mice rather than people [18][19].
Transit, stool form and the shape of the community
If you take one methodological point from this article, take this one: how fast material moves through your gut shapes both your stool and your microbiome result.
Stool consistency, scored on the Bristol Stool Scale, correlates with all the major microbiome markers — negatively with species richness, positively with the ratio of Bacteroidetes to Firmicutes [21]. When 69 host and lifestyle factors were tested against microbiome variation in two population cohorts totalling over 2,200 people, stool consistency showed the largest effect size of any of them [25].
Measuring transit objectively rather than by proxy tells the same story, with an important twist. Longer colonic transit time is associated with higher microbial richness, and simultaneously with a shift away from carbohydrate fermentation toward protein breakdown — leading the authors to state plainly that high microbial richness does not by itself imply a healthy gut ecosystem [22].
Stool form is a reasonable, imperfect proxy for transit. In the validation study that established the practice, whole-gut transit time correlated with stool form at r = −0.54 — a moderate relationship, not a deterministic one [23].
Why two people's results look so different
Inter-individual variation in the gut microbiome is large and genuine. Across a combined dataset of nearly 4,000 people, 664 genera were identified, with only a small core of 14 genera shared widely — and the authors noted that even this underexplores total diversity [25].
Two technical facts make that variation easy to misread.
First, sequencing gives proportions, not amounts. Total microbial load differs by up to tenfold between healthy individuals, so a taxon can appear to rise in a profile simply because something else fell. The apparent trade-off between Bacteroides and Prevotella, long treated as biologically meaningful, turned out to be an artefact of relative measurement [26].
Second, variability over time is itself personal. Some people carry markedly more variable communities than others, so a single sample means something different depending on whose gut it came from [27].
Diet interacts with all of this. Extreme changes in diet shift community structure within days [28], and daily sampling shows that composition reflects several days of dietary history and that individual responses to the same foods are highly personalised [31]. Yet personalisation has limits as an argument: when specific resistant starch structures were tested in a dose-response trial, responses were remarkably consistent within treatment groups, and the direction of the shift — toward propionate or toward butyrate — was determined by the chemical structure of the fibre itself [30].
What a stool microbiome test can tell you
Within the boundaries above, sequencing a stool sample can describe real things:
- ·Which bacterial groups are present in the sample, and in what relative proportions.
- ·Diversity and community-structure measures derived from those proportions.
- ·How that profile compares with reference cohorts profiled using comparable methods.
- ·With deeper sequencing, finer taxonomic resolution and the gene content the community carries [37].
These are descriptions of a sample. They are legitimate, measurable and interesting — and they are contextual biological information rather than a conclusion about your health.
What it cannot tell you
- ·It is not a picture of your whole gut. The faecal microbiome is not fully representative of the community living against the mucosa [34]. Distinct communities occupy the lumen, the mucus layers and the colonic crypts [32], and the small intestine differs again [5]. In one study using endoscopic sampling, whether the probiotic strains had actually colonised the gut lining could not be told from stool at all — the mucosal microbiome only partially correlated with the stool microbiome [33].
- ·It does not measure metabolites. Sequencing reads DNA or RNA. Short-chain fatty acid concentrations, gas volumes and bile acid profiles are separate measurements.
- ·It does not measure metabolic flux. Even a metabolite concentration is not a production rate [8][9].
- ·It does not establish cause. Associations observed across groups do not tell you what is driving anything in one person.
16S, WGS and MetaT: three different questions
The sequencing method sets a hard ceiling on what can be said, and the three approaches are not simply better and worse versions of each other.
16S rRNA amplicon sequencing profiles a single marker gene to describe which bacterial groups are present. It is well suited to broad community composition. It does not directly measure function: the authors of the most widely used functional-prediction tool state explicitly that 16S profiling "does not provide direct evidence of a community's functional capabilities," and that their method predicts function with quantifiable uncertainty [35]. Those predictions have real limits — because organisms carry different numbers of 16S gene copies, abundance estimates are biased, and benchmarking found correction tools explaining under 10% of the variance in some cases and disagreeing with each other for most communities tested [36].
Shotgun metagenomics sequences all the DNA present, adding finer taxonomic and strain-level resolution and cataloguing the genes the community carries [37]. That is genomic functional potential — the capability encoded in the community, not the activity taking place.
Metatranscriptomics sequences RNA instead, describing which genes were being transcribed at the moment of sampling. The distinction is not academic: a study pairing metagenomes and metatranscriptomes in the same people found abundant oral microbes that routinely survive the journey to the gut but are close to transcriptionally silent once there [38]. Present is not the same as active. This remains a smaller evidence base than the other two methods, and claims built on it should stay correspondingly modest.
Digestive symptoms in context
Bloating, gas, constipation, loose stools and general irregularity are common, and it is reasonable to wonder how the microbiome relates to them. The honest answer is that it is one contributing layer among several, and not a settled one.
Clinical guidance approaches bloating and distension through a broad differential that includes carbohydrate enzyme deficiencies, coeliac disease, constipation and evacuation disorders, pelvic floor dysfunction, visceral hypersensitivity and abdominophrenic dyssynergia [46]. Visceral sensitivity in particular can make otherwise unremarkable gut stimuli uncomfortable [47]. And a systematic review of the microbiome in irritable bowel syndrome was undertaken precisely because the association between gut microbiome and symptoms "has not been well established" — finding only limited consistency in direction across studies, and inconsistent diversity results [44]. The pathophysiology is described in the literature as complex and incompletely understood [45].
What can influence your result
A microbiome profile is a snapshot of one sample, on one day, processed by one method. Several things move it:
- ·Habitual diet and recent changes to it. Composition reflects several days of dietary history [31], and major changes register within days [28].
- ·Transit time and stool consistency on the day you collected — the largest single measured covariate [21][25].
- ·Antibiotics. After a four-day course of three antibiotics, healthy men returned near baseline in around 1.5 months — but nine species common to everyone beforehand were still undetectable in most of them at six months [41]. Ciprofloxacin shifted communities within 3–4 days, with often incomplete recovery [42].
- ·Other medications. Of 41 commonly used drugs examined, 19 were associated with microbial features; proton pump inhibitors, metformin, antibiotics and laxatives showed the strongest associations [39]. Proton pump inhibitor use alone is associated with lower diversity and changes in a fifth of bacterial taxa [40].
- ·Recent illness, which affects both intake and transit.
- ·Collection and handling. In systematic benchmarking, the DNA extraction protocol had a larger effect on the outcome than either library preparation or sample storage [43]. Two laboratories using different methods can report different profiles for the same stool.
- ·Ordinary day-to-day variation, the size of which differs from person to person [27]. Encouragingly, when stool consistency and composition were tracked daily for a week, the differences that mattered were between people rather than within a person across those days — which supports treating a single sample as a fair snapshot of that moment, provided you read it as a moment [24].
Reading a result well
Given all of the above, the useful posture toward a microbiome result is curiosity with calibration.
Read it as a description of a sample rather than a verdict on your gut. Check what method produced it, because the method fixes what can be said. Treat composition-based findings, inferred function, genomic potential and expression-derived signals as different grades of evidence rather than interchangeable facts. Note the conditions you sampled under — recent diet, medication, transit, illness — because those conditions are part of the result. And where a pattern interests you, treat it as a question worth following over time rather than an answer delivered on one day.
Repeat sampling under known conditions tells you more than a single profile scrutinised very hard. Population-level dietary evidence remains the best-supported foundation: the greatest reduction in risk across major health outcomes in a synthesis spanning roughly 135 million person-years was seen at 25–29 g of dietary fibre per day, with the certainty of that evidence graded moderate [4].